Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/05/008620
CTRI/2017/05/008620
Completed
未知

Incidence of Respiratory Syncytial Virus Infection in Adults Following Haematopoietic Stem Cell Transplant

A0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sitesHealth Condition 2: J20-J22- Other acute lower respiratory infectionsHealth Condition 3: null- Respiratory syncytial virus infection among adults after Haematopoietic stem cell transplant

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sitesHealth Condition 2: J20-J22- Other acute lower respiratory infectionsHealth Condition 3: null- Respiratory syncytial virus infection among adults after Haematopoietic stem cell transplant
Sponsor
A
Enrollment
50
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2019
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • •Patients must be able to give informed written consent
  • •Patients must be willing to participate in the study

Exclusion Criteria

  • •Not willing to participate
  • •Age \<18years
  • •Not able to give informed written consent
  • •Received Palivizumab prophylaxis against RSV

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Effect of respiratory syncytial viral infection on the microbiome of the upper respiratory tract * a controlled human infection study
NL-OMON51223niversitair Medisch Centrum Utrecht10
Completed
Not Applicable
Prospective Study in Respiratory Syncytial Virus Infected Japanese Adults, in Outpatient and Inpatient Settings
JPRN-UMIN000019120Janssen Pharmaceutica NV100
Recruiting
Phase 3
A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
NCT06775405Shanghai Ark Biopharmaceutical Co., Ltd.180
Enrolling By Invitation
Not Applicable
Register of Virus infections of the respiratory tract of patients with cancerJ10J12Influenza due to identified seasonal influenza virusViral pneumonia, not elsewhere classified
DRKS00015921niversitätsklinikum Jena Klinik für Innere Medizin IIAbt. Hämatologie/Internistische Onkologie1,200
Withdrawn
Not Applicable
The effect of severe respiratory syncytial virus (RSV) lower respiratory tract infections in mechanically ventilated infants younger than 12 months of age on recurrent wheezing and lung functiobronchiolitis/pneumoniaRSV lower respiratory tract infection10024970
NL-OMON34923niversitair Medisch Centrum Groningen70